Company / Current Liabilities
Foghorn Therapeutics Inc. Current Liabilities History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$59.7M
FY2025
5-year range
$18.8M / $67.0M
FY2021-FY2025
Trend
-10.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Increased from $58M to $60M over the past 2 years.
Based on SEC 10-K filings.
$60M in FY2025 with a 5-year CAGR of +26.0%.
Increased from $58M to $60M over the past 2 years.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- +2.7%
- 5-Year CAGR
- +26.0%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +26.0%, indicating consistent growth.
- In FY2025, current liabilities decreased 10.8% year-over-year.
- Peak current liabilities was recorded in FY2024.
- Lowest current liabilities in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score -1.20 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $59.7M | -10.8% |
| FY2024 | $67.0M | +14.6% |
| FY2023 | $58.4M | +5.9% |
| FY2022 | $55.2M | +192.9% |
| FY2021 | $18.8M | +0.0% |
| FY2020 | $18.8M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026